The second Trust Fertility and Gynecology Conference opened in Abu Dhabi on September 19, bringing together more than 800 specialists and experts working across fertility, reproductive health, obstetrics, gynecology, embryology and related fields.
The event is organized by Trust Fertility Clinic at Burjeel Medical City, part of Burjeel Holdings, with support and participation from the Department of Health – Abu Dhabi, and the program is designed around evidence-based and personalized approaches to reproductive medicine.
The conference features 85 speakers from 22 countries, including specialists from the United Kingdom, United States, France, Italy and Greece, alongside Emirati and UAE-based clinicians and researchers.
Its scientific program includes 28 sessions and workshops covering reproductive endocrinology, fertility preservation, endometriosis-related infertility, male infertility, embryology, fertility-enhancing surgery, medical ethics and the management of fertility care.
Participants are also examining developments in laparoscopy and hysteroscopy, the role of those procedures in diagnosing and treating conditions linked to infertility, and advances in assisted reproductive treatments and fertility-preservation techniques.
The official opening was attended by Sheikha Dr Shamma bint Mohammed bin Khalid Al Nahyan and Omniyat Al Hajeri, Executive Director of the Community Health Sector at Abu Dhabi Public Health Centre, reflecting the event’s emphasis on family health as well as specialist medical practice.
Organizers said the conference is intended to bring clinicians, researchers and decision-makers together to exchange evidence, compare clinical approaches and discuss how new technologies can be incorporated into reproductive care without losing focus on patient safety and individualized treatment.
The conference website confirms that the 2026 program runs from September 18 to September 20, with pre-conference workshops followed by the main scientific meeting, and describes the gathering as a platform for fertility medicine, gynecology, embryology and reproductive-health professionals.
The published program also places practical training alongside formal sessions, with workshops and discussions intended to connect research findings with clinical decision-making and the day-to-day patient journey from diagnosis through treatment and follow-up.
Walid Reda Sayed, Group Medical Director of Trust Fertility Clinic and conference director, said the program focuses on issues that affect the patient journey, including diagnosis, fertility preservation, treatment options and fertility-enhancing surgery, while promoting more precise and evidence-based care.
The available material describes a professional scientific conference rather than the announcement of a new treatment approval or a change in UAE fertility regulation, so Gulf Pulse is not presenting the event as evidence that any specific experimental therapy has entered routine clinical use.
For readers, the significance of the conference lies in the scale of specialist participation and the breadth of topics being discussed, while individual medical claims, technologies and treatment decisions remain matters for clinical evidence, regulation and patient-specific medical advice.
The core figures — more than 800 participants, 85 speakers, 22 countries and 28 sessions and workshops — are supported by the current Emirates News Agency report, while the conference’s own website independently confirms the event dates, organizers and broader scientific focus.
The event format also extends beyond lecture sessions, with pre-conference workshops on September 18 followed by the main conference days on September 19 and September 20, giving participants a combination of practical training, specialist discussion and broader scientific exchange across reproductive medicine and women’s health.
